corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library

Favourite items of Peter Mansfield

Page 1 of 1 pages

HSL2121
Smith R.
Curbing the Influence of the Drug Industry: A British View.
PLoS Med 2005 Aug 22:(9):e241
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0020241

HSL2069
Adair RF, Holmgren LR.
Do drug samples influence resident prescribing behavior? A randomized trial.
Am J Med 2005 Aug118:(8):881-4
http://www.amjmed.com/article/PIIS000293430500197X/fulltext

HSL1695
Zipkin DA, Steinman MA.
Interactions Between Pharmaceutical Representatives and Doctors in Training: A thematic review.
J Gen Intern Med 2005 Jun 1320:(8):777-86
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2005.0134.x

HSL2036
Henry DA, Kerridge IH, Hill SR, McNeill PM, Doran E, Newby DA, Henderson KM, Maguire J, Stokes BJ, Macdonald GJ, Day RO.
Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience.
Med J Aust 2005 Jun 6182:(11):557-60
http://www.mja.com.au/public/issues/182_11_060605/hen10805_fm.html

HSL1646
Brodkey AC.
The role of the pharmaceutical industry in teaching psychopharmacology: a growing problem.
Acad Psychiatry 2005 Sum29:(2):222-9
http://ap.psychiatryonline.org/cgi/content/full/29/2/222

HSL2070
Freudenberg N.
Public health advocacy to change corporate practices: implications for health education practice and research.
Health Educ Behav 2005 Jun32:(3):298-319
http://heb.sagepub.com/cgi/reprint/32/3/298

HSL1689
Kravitz RL, Epstein RM, Feldman MD, Franz CE, Azari R, Wilkes MS, Hinton L, Franks P.
Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.
JAMA 2005 Apr 27293:(16):1995-2002
http://jama.ama-assn.org/cgi/content/full/293/16/1995

HSL2035
Kerridge I, Maguire J, Newby D, McNeill PM, Henry D, Hill S, Day R, Macdonald G, Stokes B, Henderson K.
Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.
Intern Med J 2005 Apr35:(4):206-10
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1444-0903.2004.00799.x

HSL2033
Mansfield PR, Mintzes B, Richards D, Toop L.
Direct to consumer advertising.
BMJ 2005 Jan 1330:(7481):5-6
http://bmj.bmjjournals.com/cgi/content/full/330/7481/5

HSL1
Mansfield P.
Accepting what we can learn from advertising's mirror of desire.
BMJ 2004 Dec 18329:(7480):1487-8
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=15604193

HSL2037
Scott T, Stanford N, Thompson DR.
Killing me softly: myth in pharmaceutical advertising.
BMJ 2004 Dec 18329:(7480):1484-7
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=15604192

HSL1615
Douglas KM, Sutton RM.
Right about others, wrong about ourselves? Actual and perceived self-other differences in resistance to persuasion
Br J Soc Psychol 2004 Dec43:(Pt 4):585-603
http://www.ingentaconnect.com/content/bpsoc/bjsp/2004/00000043/00000004/art00007?token=005c10cc4e7247444f6d6222346b62687633502b333e3541333c4a2f246c6a38574b675423783c77eefc266e7e60

HSL354
Mansfield PR, Henry D.
Misleading drug promotion--no sign of improvements.
Pharmacoepidemiol Drug Saf 2004 Nov13:(11):797-9
http://www3.interscience.wiley.com/cgi-bin/abstract/107632790/ABSTRACT

HSL366
Sweet M.
Doctors and drug companies are locked in 'vicious circle'.
BMJ 2004 Oct 30329:(7473):998
http://bmj.bmjjournals.com/cgi/content/full/329/7473/998

HSL1157
Watkins RS, Kimberly J Jr.
What residents don't know about physician-pharmaceutical industry interactions.
Acad Med 2004 May79:(5):432-7
http://www.academicmedicine.org/cgi/content/full/79/5/432

HSL1420
Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E.
Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data.
Lancet 2004 Apr 24363:(9418):1341-5
http://linkinghub.elsevier.com/retrieve/pii/S0140673604160431

HSL151
Rogers WA, Mansfield PR, Braunack-Mayer AJ, Jureidini JN.
The ethics of pharmaceutical industry relationships with medical students.
Med J Aust 2004 Apr 19180:(8):411-4
http://www.mja.com.au/public/issues/180_08_190404/rog10715_fm.html

HSL1782
Breen KJ.
The medical profession and the pharmaceutical industry: when will we open our eyes?
Med J Aust 2004 Apr 19180:(8):409-10
http://www.mja.com.au/public/issues/180_08_190404/bre10055_fm.html

HSL152
Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL.
Efficacy and safety of antidepressants for children and adolescents.
BMJ 2004 Apr 10328:(7444):879-83
http://bmj.com/cgi/content/full/328/7444/879

HSL514
Schafer A.
Biomedical conflicts of interest: a defence of the sequestration thesis-learning from the cases of Nancy Olivieri and David Healy.
J Med Ethics 2004 Feb30:(1):8-24
http://jme.bmjjournals.com/cgi/content/full/30/1/8

HSL1147
Woloshin S, Schwartz LM, Welch HG.
The value of benefit data in direct-to-consumer drug ads.
Health Aff (Millwood) 2004 Jan-JunSuppl Web Exclusives:W4-234-45
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.234v1

HSL356
Svensson S, Mansfield PR.
Escitalopram: superior to citalopram or a chiral chimera?
Psychother Psychosom 2004 Jan-Feb73:(1):10-6
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=PPS2004073001010

HSL1189
Mansfield PR.
Healthy Skepticism's new AdWatch: understanding drug promotion.
Med J Aust 2003 Dec 1-15179:(11-12):644-5
http://www.mja.com.au/public/issues/179_11_011203/man10667_fm.html

HSL859
Katz D, Mansfield P, Goodman R, Tiefer L, Merz J.
Psychological aspects of gifts from drug companies.
JAMA 2003 Nov 12290:(18):2404-5
http://jama.ama-assn.org/cgi/content/full/290/18/2404-b

HSL2066
Dana J, Loewenstein G.
A social science perspective on gifts to physicians from industry.
JAMA 2003 Jul 9290:(2):252-5
http://jama.ama-assn.org/cgi/content/full/290/2/252

HSL423
Mansfield PR.
Bribes for doctors: a gift for bioethicists?
Am J Bioeth 2003 Summer3:(3):47-8

HSL1233
Cassels A, Hughes MA, Cole C, Mintzes B, Lexchin J, McCormack JP.
Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs.
CMAJ 2003 Apr 29168:(9):1133-7
http://www.cmaj.ca/cgi/content/full/168/9/1133

HSL1227
Cooper RJ, Schriger DL, Wallace RC, Mikulich VJ, Wilkes MS.
The quantity and quality of scientific graphs in pharmaceutical advertisements.
J Gen Intern Med 2003 Apr18:(4):294-7
http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0884-8734&date=2003&volume=18&issue=4&spage=294

HSL2081
Prosser H, Almond S, Walley T.
Influences on GPs' decision to prescribe new drugs-the importance of who says what.
Fam Pract 2003 Feb20:(1):61-8
http://fampra.oxfordjournals.org/cgi/content/full/20/1/61

HSL1176
Villanueva P, Peiro S, Librero J, Pereiro I.
Accuracy of pharmaceutical advertisements in medical journals.
Lancet 2003 Jan 4361:(9351):27-32
http://linkinghub.elsevier.com/retrieve/pii/S0140673603121186

HSL192
Katz D, Caplan AL, Merz JF.
All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.
Am J Bioeth 20033:(3):39-46
http://www.ingentaconnect.com/content/routledg/ajob/2003/00000003/00000003/art00027

HSL1196
Braithwaite J.
Restorative Justice and Responsive Regulation
Oxford: Oxford University Press 2002
http://www.oup.co.uk/isbn/0-19-515839-3

HSL1893
Brotons C, Moral I, Ribera A, Cascant P, Iglesias M, Permanyer-Miralda G, Ferreira Gonzalez I, Soler-Soler J.
[Methods of reporting research-results and their influence on decision-making by cardiologists prescribing drugs for primary and secondary prevention.]
Rev Esp Cardiol 2002 Oct55:(10):1042-51
http://www.revespcardiol.org/cgi-bin/wdbcgi.exe/cardio/cardioeng.acceso_full.alta

HSL2243
Loke TW, Koh FC, Ward JE.
Pharmaceutical advertisement claims in Australian medical publications.
Med J Aust 2002 Sep 16177:(6):291-3
http://www.mja.com.au/public/issues/177_06_160902/lok10004_fm.html

HSL1611
Sagarin BJ, Cialdini RB, Rice WE, Serna SB.
Dispelling the illusion of invulnerability: the motivations and mechanisms of resistance to persuasion.
J Pers Soc Psychol 2002 Sep83:(3):526-41
http://content.apa.org/journals/psp/83/3/526

HSL2077
Hall KH.
Reviewing intuitive decision-making and uncertainty: the implications for medical education.
Med Educ 2002 Mar36:(3):216-24
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1365-2923.2002.01140.x

HSL27
Mintzes B, Barer ML, Kravitz RL, Kazanjian A, Bassett K, Lexchin J, et al.
Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey
BMJ 2002324:278-279
http://bmj.bmjjournals.com/cgi/content/full/324/7332/278

HSL31
Choudhry NK, Stelfox HT, Detsky AS
Relationships between authors of clinical practice guidelines and the pharmaceutical industry
JAMA 2002287:612-617
http://jama.ama-assn.org/cgi/content/full/287/5/612

HSL33
Wilkes MS, Hoffman JR.
An innovative approach to educating medical students about pharmaceutical promotion.
Acad Med 2001 Dec76:(12):1271-1277
http://www.academicmedicine.org/cgi/content/full/76/12/1271

HSL2032
Sackett DL.
Why randomized controlled trials fail but needn't: 2 Failure to employ physiological statistics, or the only formula a clinician-trialist is ever likely to need (or understand!).
CMAJ 2001 Oct 30165:(9):1226-37
http://www.cmaj.ca/cgi/content/full/165/9/1226

HSL2146
McCormick BB, Tomlinson G, Brill-Edwards P, Detsky AS.
Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior.
JAMA 2001 Oct 24-31286:(16):1994-9
http://jama.ama-assn.org/cgi/content/full/286/16/1994

HSL41
Jones MI, Greenfield SM, Bradley CP.
Prescribing new drugs: qualitative study of influences on consultants and general practitioners
BMJ 2001323:378-384
http://bmj.bmjjournals.com/cgi/content/full/323/7309/378

HSL32
Woloshin S, Schwartz LM, Tremmel J, Welch HG
Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?
Lancet 2001358:1141-1146
http://linkinghub.elsevier.com/retrieve/pii/S0140673601062547

HSL2053
Ainslie G.
Breakdown of Will
Cambridge: Cambridge University Press 2001
http://www.cambridge.org/uk/catalogue/catalogue.asp?isbn=0521596947

HSL2099
Norman GR.
The epistemology of clinical reasoning: perspectives from philosophy, psychology, and neuroscience.
Acad Med 2000 Oct75:(10):
http://www.academicmedicine.org/cgi/content/full/75/10/S127?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Norman+G&titleabstract=epistemology&searchid=1124492605605_451&stored_search=&FIRSTINDEX=0&journalcode=acadmed

HSL216
Moynihan R, Bero L, Ross-Degnan D, Henry D, Lee K, Watkins J, Mah C, Soumerai SB.
Coverage by the news media of the benefits and risks of medications.
N Engl J Med 2000 Jun 1342:(22):1645-50
http://content.nejm.org/cgi/content/full/342/22/1645

HSL1496
Cialdini RB.
Influence: Science and Practice 4th Edn
New York: Allyn & Bacon 2000
http://www.ablongman.com/catalog/academic/product/0,1144,0321011473,00.html

HSL2038
Braithwaite J, Drahos P.
Global business regulation.
Cambridge: Cambridge University Press 2000
http://www.cambridge.org/uk/catalogue/catalogue.asp?isbn=0521784999

HSL2054
Sutherland M, Sylvester AK.
Advertising and the Mind of the Consumer 2nd Ed: What works, what doesn't, and why.
Sydney: Allen & Unwin 2000
http://www.allen-unwin.com.au/Shopping/SearchResults.aspx?search=Advertising+and+the+Mind+of+the+Consumer+

HSL2076
Elstein AS.
Heuristics and biases: selected errors in clinical reasoning.
Acad Med 1999 Jul74:(7):791-4

HSL401
Kamat VR, Nichter M.
Pharmacies, self-medication and pharmaceutical marketing in Bombay, India.
Soc Sci Med 1998 Sep47:(6):779-94
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-3T3SS6V-1H&_coverDate=09%2F16%2F1998&_alid=305663279&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5925&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=77260eaace668b4e4f2bdc8361b37ee6

HSL380
Roughead EE, Harvey KJ, Gilbert AL.
Commercial detailing techniques used by pharmaceutical representatives to influence prescribing.
Aust N Z J Med 1998 Jun28:(3):306-10

HSL408
Stelfox HT, Chua G, O'Rourke K, Detsky AS.
Conflict of interest in the debate over calcium-channel antagonists.
N Engl J Med 1998 Jan 8338:(2):101-6
http://content.nejm.org/cgi/content/abstract/338/2/101

HSL381
Roughead EE, Gilbert AL, Harvey KJ.
Self-regulatory codes of conduct: are they effective in controlling pharmaceutical representatives' presentations to general medical practitioners?
Int J Health Serv 199828:(2):269-79

HSL1894
Lexchin J.
What information do physicians receive from pharmaceutical representatives?
Can Fam Physician 1997 May43:941-5

HSL2034
Stryer D, Bero LA.
Characteristics of materials distributed by drug companies. An evaluation of appropriateness.
J Gen Intern Med 1996 Oct11:(10):575-83

HSL582
Wolfe S.
Drug advertisements that go straight to the hippocampus.
Lancet 1996 Sep 7348:(9028):632

HSL2039
Estes R.
Tyrany of the bottom line: Why corporations make good people do bad things.
San Francisco: Berrett-Koehler 1996
http://www.bkconnection.com/ProdDetails.asp?ID=1881052753&PG=1&Type=BL&PCS=BKP

HSL2068
Barlow J, Møller C.
A complaint is a gift. Using customer feedback as a strategic tool.
San Francisco: Berrett-Koehler 1996
http://www.bkconnection.com/ProdDetails.asp?ID=1881052818&PG=1&Type=RLMa&PCS=BKP

HSL645
Ziegler MG, Lew P, Singer BC.
The accuracy of drug information from pharmaceutical sales representatives.
JAMA 1995 Apr 26273:(16):1296-8

HSL364
Lexchin J.
Deception by design: Pharmaceutical promotion in the Third World
Penang: Consumers International 1995

HSL1455
Bardelay D, Bécel B.
Visits from medical representatives: fine principles, poor practice
Prescrire International 19954:(18):120-122

HSL2067
Ogilvy D.
Ogilvy on advertising.
London: Prion 1995
http://www.randomhouse.com/vintage/catalog/display.pperl?isbn=9780394729039

HSL2093
Branthwaite A, Downing T.
Marketing to doctors - the human factor.
Scrip Magazine 199532-5

HSL6455
Shaughnessy AF, Slawson DC, Bennett JH.
Separating the wheat from the chaff: identifying fallacies in pharmaceutical promotion.
J Gen Intern Med 1994 Oct9:(10):563-8

HSL6454
Scott DK, Ferner RE.
'The strategy of desire' and rational prescribing.
Br J Clin Pharmacol 1994 Mar37:(3):217-9

HSL2043
Ayres I, Braithwaite J.
Responsive regulation: Transcending the deregulation debate.
Oxford: Oxford University Press 1992
http://www.oup.co.uk/isbn/0-19-509376-3

HSL1324
Goleman D.
Vital lies, simple truths: The psychology of self-deception.
London: Bloomsbury 1985
http://www.amazon.com/exec/obidos/tg/detail/-/0684831074/103-6888207-0054229?v=glance

HSL2065
Avorn J, Chen M, Hartley R.
Scientific versus commercial sources of influence on the prescribing behavior of physicians.
Am J Med 1982 Jul73:(1):4-8

HSL2075
Kahneman D, Slovic P, Tversky A.
Judgment under uncertainty: heuristics and biases.
New York: Cambridge University Press 1982
http://www.cambridge.org/uk/catalogue/catalogue.asp?isbn=0521284147

HSL2047
Fischer DH.
Historian's Fallacies: Toward a logic of historical thought.
New York: Harper Torchbooks 1970
http://www.amazon.com/exec/obidos/tg/detail/-/0061315451/002-4340062-2313626?v=glance

HSL2080
Hamblin CL.
Fallacies
London: Methuen 1970
http://www.valepress.com/Fallacies.htm

HSL2060
Talalay P, Editor.
Drugs in Our Society.
Baltimore: John Hopkins Press 1964
http://www.amazon.com/exec/obidos/tg/detail/-/0801806194/qid=1124494429/sr=1-1/ref=sr_1_1/002-4340062-2313626?v=glance&s=books

HSL2041
Hopkins CC.
My Life in Advertising.
Chicago: 1996 reprint by NTC Business Books 1927
http://books.mcgraw-hill.com/getbook.php?isbn=0844231010&template=

HSL2042
Hopkins CC.
Scientific advertising.
Chicago: 1996 reprint by NTC Business Books 1923
http://books.mcgraw-hill.com/getbook.php?isbn=0844231010&template=

HSL693
Locke J.
An essay concerning human understanding
1690
http://etext.library.adelaide.edu.au/l/locke/john/l81u/index.html

HSL692
Aristotle.
Rhetoric.
Date uncertain 350 350 BCE
http://www.public.iastate.edu/~honeyl/Rhetoric/index.html

Page 1 of 1 pages

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.







Cases of wilful misrepresentation are a rarity in medical advertising. For every advertisement in which nonexistent doctors are called on to testify or deliberately irrelevant references are bunched up in [fine print], you will find a hundred or more whose greatest offenses are unquestioning enthusiasm and the skill to communicate it.

The best defence the physician can muster against this kind of advertising is a healthy skepticism and a willingness, not always apparent in the past, to do his homework. He must cultivate a flair for spotting the logical loophole, the invalid clinical trial, the unreliable or meaningless testimonial, the unneeded improvement and the unlikely claim. Above all, he must develop greater resistance to the lure of the fashionable and the new.
- Pierre R. Garai (advertising executive) 1963